1
|
Madariaga MC, O'Malley NA, Groff H, Alben M, Papalia A, Fogel J, Thompson J, Apazidis A. Does hydrogen peroxide help mitigate the incidence of Cutibacterium acnes in cervical spine surgeries? NORTH AMERICAN SPINE SOCIETY JOURNAL 2024; 19:100514. [PMID: 39175928 PMCID: PMC11339044 DOI: 10.1016/j.xnsj.2024.100514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/16/2024] [Revised: 06/06/2024] [Accepted: 06/25/2024] [Indexed: 08/24/2024]
Abstract
Background Surgical site infection (SSI) is a common yet serious complication of cervical spine surgery. While initially thought to be clinically insignificant, Cutibacterium acnes (C. acnes) is an important cause of infection. The purpose of this study was to investigate the ability of a hydrogen peroxide (H2O2) application during standard presurgical skin preparation to reduce the burden of C. acnes in patients undergoing cervical spine surgery. Methods This was a retrospective review of prospectively collected data. Subjects were randomly assigned to either standard surgical preparation plus H2O2 (experimental) or without H2O2 (control). Prescrub, postscrub, and dermal cultures were obtained to assess the C. acnes burden after cultures on an aerobic and anaerobic growth medium were held for 21 days. Multivariate analysis was conducted to determine factors associated with presence of C. acnes. Outcome measures included the results of intraoperative cultures and the development of a SSI within 90 days postoperatively. Results Patients (n=86) undergoing elective 2- or 3-level fusion via anterior approach were included. Prior to application of the antiseptic solution, 65% (28/43) of the experimental cohort and 77% (33/43) of the control cohort had positive C. acnes cultures (p=.34). Following application of antiseptic solution, there were no differences in positive C. acnes culture rates between the experimental and control cohorts in the epidermal (30% vs. 28%, p=1.00) or dermal (40% vs. 42%, p=1.00) cultures. No differences in the rates of C. acnes eradication from preantiseptic to postantiseptic application occurred for epidermal (p=1.00) or dermal (p=1.00) skin layers. None of the factors were associated with positive C. acnes epidermal cultures on multivariable logistic regression analysis (p>.05). Conclusions While there is potential for H2O2 to reduce the positive culture rate of C. acnes in cervical spine patients, no difference was seen when compared to standard surgical skin preparation.
Collapse
Affiliation(s)
| | - Nicholas A. O'Malley
- Department of Orthopaedic Surgery, Nassau University Medical Center, East Meadow, NY 11554
| | - Hannah Groff
- Department of Orthopaedic Surgery, Nassau University Medical Center, East Meadow, NY 11554
| | - Matthew Alben
- State University at Buffalo, Department of Orthopedic Surgery, Buffalo, NY
| | - Aidan Papalia
- Geisnger Health, Department of Orthopedic Surgery, Danville, PA
| | - Joshua Fogel
- Department of Biostatistics, Nassau University Medical Center, East Meadow, NY 11554
| | - Jeffrey Thompson
- Department of Orthopaedic Surgery, Nassau University Medical Center, East Meadow, NY 11554
| | - Alexios Apazidis
- Department of Orthopaedic Surgery, Nassau University Medical Center, East Meadow, NY 11554
| |
Collapse
|
2
|
Baroudi M, Daher M, Parks RD, Gregoryczyk JG, Balmaceno-Criss M, McDonald CL, Diebo BG, Daniels AH. Cutibacterium acnes in spine surgery: pathophysiology, diagnosis, and treatment. Spine J 2024; 24:1545-1552. [PMID: 38679079 DOI: 10.1016/j.spinee.2024.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/27/2024] [Revised: 04/23/2024] [Accepted: 04/23/2024] [Indexed: 05/01/2024]
Abstract
Cutibacterium acnes (C. acnes) previously named Propionibacterium acnes (P. acnes) has been increasingly recognized by spine surgeons as a cause of indolent postsurgical spinal infection. Patients infected with C. acnes may present with pseudarthrosis or nonspecific back pain. Currently, microbiological tissue cultures remain the gold standard in diagnosing C. acnes infection. Ongoing research into using genetic sequencing as a diagnostic method shows promising results and may be another future way of diagnosis. Optimized prophylaxis involves the use of targeted antibiotics, longer duration of antibiotic prophylaxis, antibacterial-coated spinal implants, and evidence-based sterile surgical techniques all of which decrease contamination. Antibiotics and implant replacement remain the mainstay of treatment, with longer durations of antibiotics proving to be more efficacious. Local guidelines must consider the surge of antimicrobial resistance worldwide when treating C. acnes.
Collapse
Affiliation(s)
- Makeen Baroudi
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Mohammad Daher
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Russell D Parks
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Jerzy George Gregoryczyk
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Mariah Balmaceno-Criss
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Christopher L McDonald
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Bassel G Diebo
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA
| | - Alan H Daniels
- Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, Providence, RI 02914, USA.
| |
Collapse
|
3
|
Wei J, Brown C, Moore T, Graham N, Davis M, Gatehouse S, Nourse C. Implant-associated Infection After Pediatric Spine Deformity Surgery: Is Removal of Hardware Indicated? Pediatr Infect Dis J 2024; 43:333-338. [PMID: 38100726 DOI: 10.1097/inf.0000000000004218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2023]
Abstract
BACKGROUND Postoperative spinal implant infection following pediatric spinal surgery often presents a management dilemma. We aimed to characterize our experience in this cohort of patients, hoping to provide further insight when approaching these challenging cases. METHODS A retrospective, observational study was performed of all children who underwent spinal surgery from January 2015 to June 2021 in a tertiary pediatric spinal surgery referral center in Queensland, Australia. Records were reviewed to identify cases of postoperative surgical site infection, with particular focus on children with infection directly involving implants. Preoperative prophylaxis, microbiology, clinical course and outcomes were analyzed. RESULTS A total of 580 children underwent 933 procedures during the study period. The most common pathology requiring surgery was idiopathic scoliosis in 257 children (44.3%) followed by neuromuscular scoliosis in 192 children (33.1%). There were 35 cases of surgical site infection (6.03%), and 9 were implant-associated (1.55%). Infection rate among children with neuromuscular spinal deformity was almost 3-fold higher (11.5%) than idiopathic (3.89%). Methicillin-sensitive Staphylococcus aureus was the most commonly isolated organism (n = 15). Four implant-associated infections were successfully managed with retention of implant; all were diagnosed within 32 days (median = 20 days) and cultured either Staphylococcus aureus or Pseudomonas aeruginosa . Conversely, infections that necessitated implant removal had a more indolent onset (median = 175 days), and more often cultured Cutibacterium acnes and coagulase-negative Staphylococci . CONCLUSIONS Postoperative spinal implant infection can be treated successfully with hardware retention in select cases. Earlier presentation and recognition appear to be associated with better rates of retention and are linked to certain organisms. Further exploration of specific preventative strategies may be key in preventing devastating late-onset infections.
Collapse
Affiliation(s)
- Jou Wei
- From the Queensland Children's Hospital
| | | | - Tomas Moore
- Graduate Medical School, University of Queensland
| | | | | | | | - Clare Nourse
- From the Queensland Children's Hospital
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|
4
|
Núñez-Pereira S, Benavent E, Ulldemolins M, Sobrino-Díaz B, Iribarren JA, Escudero-Sánchez R, Del Toro MD, Nodar A, Sorli L, Bahamonde A, Vilchez HH, Gasch O, Muñez E, Rodríguez-Montserrat D, García-País MJ, Haddad S, Sellarès-Nadal J, Murillo O, Rodríguez-Pardo D. Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study. Antibiotics (Basel) 2023; 12:antibiotics12030518. [PMID: 36978385 PMCID: PMC10044575 DOI: 10.3390/antibiotics12030518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2023] [Revised: 02/25/2023] [Accepted: 03/02/2023] [Indexed: 03/08/2023] Open
Abstract
Infection after spinal instrumentation (IASI) by Cutibacterium spp. is being more frequently reported. The aim of this study was to analyse the incidence, risk factors, clinical characteristics, and outcome of a Cutibacterium spp. IASI (CG) compared with non-Cutibacterium IASI (NCG) infections, with an additional focus on the role of rifampin in the treatment. All patients from a multicentre, retrospective, observational study with a confirmed IASI between January 2010 and December 2016 were divided into two groups: (CG and NCG) IASI. Baseline, medical, surgical, infection treatment, and follow-up data were compared for both groups. In total, 411 patients were included: 27 CG and 384 NCG. The CG patients were significantly younger. They had a longer median time to diagnosis (23 vs. 13 days) (p = 0.025), although 55.6% debuted within the first month after surgery. Cutibacterium patients were more likely to have the implant removed (29.6% vs. 12.8%; p = 0.014) and received shorter antibiotic regimens (p = 0.014). In 33% of Cutibacterium cases, rifampin was added to the baseline therapy. None of the 27 infections resulted in treatment failure during follow-up regardless of rifampin use. Cutibacterium spp. is associated with a younger age and may cause both early and late IASIs. In our experience, the use of rifampin to improve the outcome in the treatment of a Cutibacterium spp. IASI is not relevant since, in our series, none of the cases had therapeutic failure regardless of the use of rifampin.
Collapse
Affiliation(s)
- Susana Núñez-Pereira
- Spine Unit, Orthopaedic Surgery Department, Vall d’Hebron University Hospital, 08035 Barcelona, Spain
- Correspondence: (S.N.-P.); (D.R.-P.); Tel.: +34-934893480 (S.N.-P)
| | - Eva Benavent
- Infectious Diseases Department, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Marta Ulldemolins
- Infectious Diseases Department, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Beatriz Sobrino-Díaz
- Department of Infectious Diseases, Hospital Regional Universitario Málaga, 29011 Málaga, Spain
| | - José A. Iribarren
- Infectious Diseases Department, Hospital Universitario Donostia, 20014 Gipuzkoa, Spain
| | - Rosa Escudero-Sánchez
- Infectious Disease Department, University Hospital Ramón y Cajal, 28034 Madrid, Spain
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
| | - María Dolores Del Toro
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
- Infectious Diseases Unit, Hospital Universitario Virgen Macarena, 41009 Seville, Spain
- Departamento de Medicina, Instituto de Biomedicina de Sevilla (IBiS), Universidad de Sevilla, 41009 Seville, Spain
| | - Andrés Nodar
- Infectious Diseases Unit, Internal Medicine Department, 36312 Vigo, Spain
- Instituto de Investigación Biomédica Galicia Sur, Hospital Álvaro Cunqueiro, 36312 Vigo, Spain
| | - Luisa Sorli
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
- Infectious Diseases Department, Hospital del Mar, 08003 Barcelona, Spain
- Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), CEXS-Universitat Pompeu Fabra, 08003 Barcelona, Spain
| | - Alberto Bahamonde
- Department of Internal Medicine-Infectious Diseases, Hospital Universitario del Bierzo, 24411 Ponferrada, Spain
| | - Helem H. Vilchez
- Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario Son Espases, 07120 Palma de Mallorca, Spain
| | - Oriol Gasch
- Infectious Diseases Department, Hospital Parc Tauli de Sabadell, University Autonoma of Barcelona, 08208 Barcelona, Spain
| | - Elena Muñez
- Infectious Diseases Unit, Internal Medicine Department, Hospital Puerta de Hierro-Majadahonda, 28222 Madrid, Spain
| | | | - María José García-País
- Infectious Disease Unit and Microbiology Departments, Hospital Universitario Lucus Augusti, 27003 Lugo, Spain
| | - Sleiman Haddad
- Spine Unit, Orthopaedic Surgery Department, Vall d’Hebron University Hospital, 08035 Barcelona, Spain
| | - Julia Sellarès-Nadal
- Infectious Diseases Department, Vall d’Hebron, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- Medicine Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
| | - Oscar Murillo
- Infectious Diseases Department, Hospital Universitari de Bellvitge, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
| | - Dolors Rodríguez-Pardo
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
- Infectious Diseases Department, Vall d’Hebron, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
- Medicine Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
- Correspondence: (S.N.-P.); (D.R.-P.); Tel.: +34-934893480 (S.N.-P)
| | | |
Collapse
|
5
|
Dadkhahfar S, Ohadi L, Biglari F, Jafari Kafiabadi M. Surgical site infection following orthopedic surgery in a patient with acne: A challenging case. Clin Case Rep 2022; 10:e6700. [PMID: 36514471 PMCID: PMC9731166 DOI: 10.1002/ccr3.6700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/09/2022] [Accepted: 11/18/2022] [Indexed: 12/14/2022] Open
Abstract
Propionibacterium acnes is a typical component of the human body's flora and has been implicated as the causative infectious agent following a variety of operations, including device installation. We present a case of a 21-year-old male patient with severe global acneiform eruption with a non-healing limb lesion near the orthopedic surgery incisions.
Collapse
Affiliation(s)
- Sahar Dadkhahfar
- Skin Research CenterShahid Beheshti University of Medical SciencesTehranIran
| | - Laya Ohadi
- Shahid Beheshti University of medical sciencesTehranIran
| | - Farsad Biglari
- Department of Orthopedic SurgeryClinical Research Development Unit of Shohada‐e Tajrish HospitalShahid Beheshti University of Medical SciencesTehranIran
| | - Meisam Jafari Kafiabadi
- Department of Orthopedic SurgeryClinical Research Development Unit of Shohada‐e Tajrish HospitalShahid Beheshti University of Medical SciencesTehranIran
| |
Collapse
|
6
|
He K, Nayak RB, Allori AC, Brighton BK, Cina RA, Ellison JS, Goretsky MJ, Jatana KR, Proctor MR, Grant C, Thompson VM, Iwaniuk M, Cohen ME, Saito JM, Hall BL, Newland JG, Ko CY, Rangel SJ. Correlation Between Postoperative Antimicrobial Prophylaxis Use and Surgical Site Infection in Children Undergoing Nonemergent Surgery. JAMA Surg 2022; 157:1142-1151. [PMID: 36260310 PMCID: PMC9582965 DOI: 10.1001/jamasurg.2022.4729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Accepted: 07/24/2022] [Indexed: 01/11/2023]
Abstract
Importance Use of postoperative antimicrobial prophylaxis is common in pediatric surgery despite consensus guidelines recommending discontinuation following incision closure. The association between postoperative prophylaxis use and surgical site infection (SSI) in children undergoing surgical procedures remains poorly characterized. Objective To evaluate whether use of postoperative surgical prophylaxis is correlated with SSI rates in children undergoing nonemergent surgery. Design, Setting, and Participants This is a multicenter cohort study using 30-day postoperative SSI data from the American College of Surgeons' Pediatric National Surgical Quality Improvement Program (ACS NSQIP-Pediatric) augmented with antibiotic-use data obtained through supplemental medical record review from June 2019 to June 2021. This study took place at 93 hospitals participating in the ACS NSQIP-Pediatric Surgical Antibiotic Prophylaxis Stewardship Collaborative. Participants were children (<18 years of age) undergoing nonemergent surgical procedures. Exclusion criteria included antibiotic allergies, conditions associated with impaired immune function, and preexisting infections requiring intravenous antibiotics at time of surgery. Exposures Continuation of antimicrobial prophylaxis beyond time of incision closure. Main Outcomes and Measures Thirty-day postoperative rate of incisional or organ space SSI. Hierarchical regression was used to estimate hospital-level odds ratios (ORs) for SSI rates and postoperative prophylaxis use. SSI measures were adjusted for differences in procedure mix, patient characteristics, and comorbidity profiles, while use measures were adjusted for clinically related procedure groups. Pearson correlations were used to examine the associations between hospital-level postoperative prophylaxis use and SSI measures. Results Forty thousand six hundred eleven patients (47.3% female; median age, 7 years) were included, of which 41.6% received postoperative prophylaxis (hospital range, 0%-71.2%). Odds ratios (ORs) for postoperative prophylaxis use ranged 190-fold across hospitals (OR, 0.10-19.30) and ORs for SSI rates ranged 4-fold (OR, 0.55-1.90). No correlation was found between use of postoperative prophylaxis and SSI rates overall (r = 0.13; P = .20), and when stratified by SSI type (incisional SSI, r = 0.08; P = .43 and organ space SSI, r = 0.13; P = .23), and surgical specialty (general surgery, r = 0.02; P = .83; urology, r = 0.05; P = .64; plastic surgery, r = 0.11; P = .35; otolaryngology, r = -0.13; P = .25; orthopedic surgery, r = 0.05; P = .61; and neurosurgery, r = 0.02; P = .85). Conclusions and Relevance Use of postoperative surgical antimicrobial prophylaxis was not correlated with SSI rates at the hospital level after adjusting for differences in procedure mix and patient characteristics.
Collapse
Affiliation(s)
- Katherine He
- Department of Surgery, Boston Children’s Hospital, Boston, Massachusetts
| | | | - Alexander C. Allori
- Division of Plastic, Maxillofacial & Oral Surgery, Department of Surgery, Duke University Health System, Durham, North Carolina
| | - Brian K. Brighton
- Department of Orthopedic Surgery, Levine Children's Hospital/Carolinas HealthCare System, Charlotte, North Carolina
| | | | - Jonathan S. Ellison
- Department of Urology, Medical College of Wisconsin & Children’s Wisconsin, Milwaukee
| | | | - Kris R. Jatana
- Department of Otolaryngology-Head and Neck Surgery, Nationwide Children’s Hospital, Columbus, Ohio
| | - Mark R. Proctor
- Department of Neurosurgery, Boston Children’s Hospital, Boston, Massachusetts
| | | | | | | | | | - Jacqueline M. Saito
- Department of Surgery, Washington University St Louis School of Medicine, and BJC Healthcare, St Louis, Missouri
| | - Bruce L. Hall
- American College of Surgeons, Chicago, Illinois
- Department of Surgery, Washington University St Louis School of Medicine, and BJC Healthcare, St Louis, Missouri
| | - Jason G. Newland
- Department of Pediatrics, Washington University St Louis School of Medicine, St Louis, Missouri
| | | | - Shawn J. Rangel
- Department of Surgery, Boston Children’s Hospital, Boston, Massachusetts
| |
Collapse
|
7
|
Mallet C, Meissburger V, Caseris M, Happiette A, Chinnappa J, Bonacorsi S, Simon AL, Ilharreborde B. Does the use of intrawound povidone-iodine irrigation and local vancomycin powder impact surgical site infection rate in adolescent idiopathic scoliosis surgery? EUROPEAN SPINE JOURNAL : OFFICIAL PUBLICATION OF THE EUROPEAN SPINE SOCIETY, THE EUROPEAN SPINAL DEFORMITY SOCIETY, AND THE EUROPEAN SECTION OF THE CERVICAL SPINE RESEARCH SOCIETY 2022; 31:3020-3028. [PMID: 35913622 DOI: 10.1007/s00586-022-07340-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2021] [Revised: 05/17/2022] [Accepted: 07/20/2022] [Indexed: 06/15/2023]
Abstract
PURPOSE Surgical site infection (SSI) is a major complication after adolescent idiopathic scoliosis (AIS) surgery, with an incidence ranging from 0.5 to 7%. Intraoperative wound decontamination with povidone-iodine (PVP-I) irrigation and/or vancomycin powder in adult spinal surgery has gained attention in the literature with controversial results. The aim of this study was to investigate the impact of using intrawound PVP-I irrigation and local vancomycin powder (LVP) on the incidence of early SSI in AIS surgery. METHODS All AIS patients who underwent posterior spinal fusion between October 2016 and December 2019 were retrospectively reviewed. The incidence of early SSI was reported and compared between 2 groups defined by the treating spinal surgeons' preferences: group 1-intrawound irrigation with 2L of PVP-I and application of 3 g LVP before closure and control group 2-patients that did not receive either of these measures. RESULTS Nine early cases of SSI (2.9%) were reported among the 307 AIS posterior spinal fusion patients. Incidence of SSI in group 1 (2/178 = 1.1%) was significantly lower than in group 2 (7/129 = 5.4%; p = 0.04). There were no adverse reactions to the use of PVP-I and LVP in our study. At latest follow-up, rate of surgical revision for mechanical failure with pseudarthrosis was significantly lower in group 1 (2/178 = 1.1%) than in group 2 (9/129 = 7.0%; p = 0.01). CONCLUSION Intraoperative use of intrawound PVP-I irrigation and vancomycin powder is associated with a significant reduction of early SSI after AIS spine surgery. LEVEL OF EVIDENCE IV Retrospective study.
Collapse
Affiliation(s)
- Cindy Mallet
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France.
| | - Victor Meissburger
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France
| | - Marion Caseris
- Pediatric Infectious Disease Department, Robert Debré University Hospital, Paris Diderot University, Paris, France
| | - Adèle Happiette
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France
| | - Jason Chinnappa
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France
| | - Stéphane Bonacorsi
- Microbiology Department, Robert Debré University Hospital, Paris Diderot university, Paris, France
| | - Anne-Laure Simon
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France
| | - Brice Ilharreborde
- Pediatric Orthopedic Department, Robert Debré University Hospital, Paris Diderot University, 48 boulevard sérurier, 75019, Paris, France
| |
Collapse
|